Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells

Journal of Cellular Biochemistry

Volumn 111, Issue 5, 2010, Pages 1107-1113

  Kim, Hyun Ju ^a,b   Warren, Julia T ^a   Kim, Shin Yoon ^b   Chappel, Jean C ^a   DeSelm, Carl J ^a   Ross, F Patrick ^a   Zou, Wei ^a   Teitelbaum, Steven L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Fyn; M CSF; osteoclasts; RANK ligand; Src family kinase (SFK)

Indexed keywords

BIM PROTEIN; LIGAND; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C JUN; PROTEIN KINASE B; PROTEIN KINASE FYN;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL FUNCTION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FAMILY; IN VITRO STUDY; IN VIVO STUDY; MOLECULE; MOUSE; NONHUMAN; ONCOGENE SRC; ORGANIZATION; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRECURSOR; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BONE RESORPTION; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURVIVAL; MICE; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FYN; RANK LIGAND;

EID: 78649840902     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22841     Document Type: Article

References (34)

1. Abu-Amer Y, Ross FP, Edwards J, Teitelbaum SL,. 1997. Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor. J Clin Invest 100: 1557-1565.
2. Akiyama T, Bouillet P, Miyazaki T, Kadono Y, Chikuda H, Chung UI, Fukuda A, Hikita A, Seto H, Okada T, Inaba T, Sanjay A, Baron R, Kawaguchi H, Oda H, Nakamura K, Strasser A, Tanaka S,. 2003. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J 22: 6653-6664.
3. Bai S, Kitaura H, Zhao H, Chen J, Muller JM, Schule R, Darnay B, Novack DV, Ross FP, Teitelbaum SL,. 2005. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest 115: 2742-2751.
4. Beggs HE, Baragona SC, Hemperly JJ, Maness PF,. 1997. NCAM140 interacts with the focal adhesion kinase p125(fak) and the SRC-related tyrosine kinase p59(fyn). J Biol Chem 272: 8310-8319.
5. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR,. 1992. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90: 1622-1627.
6. Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W,. 2005. Vav3 regulates osteoclast function and bone mass. Nat Med 11: 284-290.
7. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ,. 1998. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188: 997-1001.
8. Jimi E, Akiyama S, Tsurukai T, Okahashi N, Kobayashi K, Udagawa N, Nishihara T, Takahashi N, Suda T,. 1999. Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163: 434-442. (Pubitemid 29295871)
9. Karin M, Cao Y, Greten FR, Li ZW,. 2002. NF-kappaB in cancer: From innocent bystander to major culprit. Nat Rev Cancer 2: 301-310.
10. Kim HJ, Zhao H, Kitaura H, Bhattacharyya S, Brewer JA, Muglia LJ, Ross FP, Teitelbaum SL,. 2006. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116: 2152-2160.
11. Kim HJ, Zhang K, Zhang L, Ross FP, Teitelbaum SL, Faccio R,. 2009. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. Proc Natl Acad Sci USA 106: 2325-2330.
12. Kojima N, Wang J, Mansuy IM, Grant SG, Mayford M, Kandel ER,. 1997. Rescuing impairment of long-term potentiation in fyn-deficient mice by introducing Fyn transgene. Proc Natl Acad Sci USA 94: 4761-4765.
13. Lacey DL, Tan HL, Lu J, Kaufman S, Van G, Qiu W, Rattan A, Scully S, Fletcher F, Juan T, Kelley M, Burgess TL, Boyle WJ, Polverino AJ,. 2000. Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 157: 435-448.
14. Lakkakorpi P, Nakamura I, Young M, Lipfert L, Rodan G, Duong L,. 2001. Abnormal localisation and hyperclustering of (alpha)(V)(beta)(3) integrins and associated proteins in Src-deficient or tyrphostin A9-treated osteoclasts. J Cell Sci 114: 149-160.
15. Lee ZH, Kim H-H,. 2003. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 305: 211-214.
16. Lowell CA, Soriano P,. 1996. Knockouts of Src-family kinases: Stiff bones, wimpy T cells, and bad memories. Genes Dev 10: 1845-1857.
17. Manie SN, Astier A, Haghayeghi N, Canty T, Druker BJ, Hirai H, Freedman AS,. 1997. Regulation of integrin-mediated p130(Cas) tyrosine phosphorylation in human B cells. A role for p59(Fyn) and SHP2. J Biol Chem 272: 15636-15641.
18. Martin-Cofreces NB, Sancho D, Fernandez E, Vicente-Manzanares M, Gordon-Alonso M, Montoya MC, Michel F, Acuto O, Alarcon B, Sanchez-Madrid F,. 2006. Role of Fyn in the rearrangement of tubulin cytoskeleton induced through TCR. J Immunol 176: 4201-4207.
19. Nishida K, Yamasaki S, Ito Y, Kabu K, Hattori K, Tezuka T, Nishizumi H, Kitamura D, Goitsuka R, Geha RS, Yamamoto T, Yagi T, Hirano T,. 2005. FcÎμRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol 170: 115-126.
20. Novack DV, Yin L, Hagen-Stapleton A, Schreiber RD, Goeddel DV, Ross FP, Teitelbaum SL,. 2003. The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J Exp Med 198: 771-781.
21. O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML, Huang DC, Strasser A,. 2000. The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells. Am J Pathol 157: 449-461.
22. Parravicini V, Gadina M, Kovarova M, Odom S, Gonzalez-Espinosa C, Furumoto Y, Saitoh S, Samelson LE, O'Shea JJ, Rivera J,. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3: 741-748.
23. Reeve JL, Zou W, Liu Y, Maltzman JS, Ross FP, Teitelbaum SL,. 2009. SLP-76 couples Syk to the osteoclast cytoskeleton. J Immunol 183: 1804-1812.
24. Soriano P, Montgomery C, Geske R, Bradley A,. 1991. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64: 693-702.
25. Stein PL, Lee HM, Rich S, Soriano P,. 1992. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70: 741-750.
26. Sugatani T, Hruska KA,. 2005. Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583-3589.
27. Takeshita S, Faccio R, Chappel J, Zheng L, Feng X, Weber JD, Teitelbaum SL, Ross FP,. 2007. c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages. J Biol Chem 282: 18980-18990.
28. Tanaka S, Nakamura K, Takahasi N, Suda T,. 2005. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 208: 30-49.
29. Teitelbaum SL,. 2007. Osteoclasts: What do they do and how do they do it? Am J Pathol 170: 427-435.
30. Teitelbaum SL, Ross FP,. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649.
31. Umemori H, Sato S, Yagi T, Aizawa S, Yamamoto T,. 1994. Initial events of myelination involve Fyn tyrosine kinase signalling. Nature 367: 572-576.
32. Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R, Novack DV,. 2008. RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest 118: 2088-2097.
33. Wong BR, Besser D, Kim N, Arron JR, Vologodskaia M, Hanafusa H, Choi Y,. 1999. TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4: 1041-1049.
34. Zou W, Reeve JL, Liu Y, Teitelbaum SL, Ross FP,. 2008. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol Cell 31: 422-431.